• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布他比妥对辣椒素诱导的三叉神经脊束核中c-fos样免疫反应性的减弱作用。

Attenuation by butalbital of capsaicin-induced c-fos-like immunoreactivity in trigeminal nucleus caudalis.

作者信息

Cutrer F M, Mitsikostas D D, Ayata G, Sanchez del Rio M

机构信息

Departments of Neurology and Neurosurgery, Massachusetts General Hospital, 149 13th Street, CNY 6403, Charlestown, MA 02129, USA.

出版信息

Headache. 1999 Nov-Dec;39(10):697-704. doi: 10.1046/j.1526-4610.1999.3910697.x.

DOI:10.1046/j.1526-4610.1999.3910697.x
PMID:11279945
Abstract

We examined the effects of butalbital (30, 100, and 1000 micrograms/kg) on the number of cells expressing c-fos-like immunoreactivity (c-fos-LI), a marker of neuronal activation, within lamina I, IIo of the trigeminal nucleus caudalis and the nucleus of the solitary tract 2 hours after the intracisternal injection of capsaicin (0.1 mL; 15.25 mg/mL) or vehicle in urethane-anesthetized guinea pigs (N = 45). Robust c-fos-LI was observed within nuclei of cells in the trigeminal nucleus caudalis after capsaicin (329 +/- 35). Butalbital dose-dependently reduced the number of labeled cells to a maximum of 66% (1000 micrograms/kg intraperitoneally [i.p.], P < .01) in lamina I, IIo but not within area postrema, medial reticular nucleus, or the nucleus of the solitary tract. Pretreatment with bicuculline (30 micrograms/kg i.p.) blocked the effect of butalbital, thereby suggesting the importance of the GABAA receptor to activation involved in the transmission of nociceptive information. Our studies suggest the possibility that GABAA receptors might provide an important therapeutic target in migraine and related headache disorders.

摘要

我们在氨基甲酸乙酯麻醉的豚鼠(N = 45)中,于脑池内注射辣椒素(0.1 mL;15.25 mg/mL)或赋形剂2小时后,研究了布他比妥(30、100和1000微克/千克)对三叉神经尾侧核I层、IIo层以及孤束核中表达c-fos样免疫反应性(c-fos-LI,神经元激活标志物)的细胞数量的影响。注射辣椒素后,在三叉神经尾侧核的细胞核内观察到强烈的c-fos-LI(329 ± 35)。布他比妥剂量依赖性地减少了I层、IIo层中标记细胞的数量,最大减少至66%(腹腔注射1000微克/千克,P < 0.01),但在最后区、内侧网状核或孤束核中未观察到这种现象。用荷包牡丹碱(腹腔注射30微克/千克)预处理可阻断布他比妥的作用,这表明GABAA受体对伤害性信息传递中涉及的激活过程很重要。我们的研究表明,GABAA受体可能是偏头痛及相关头痛疾病的一个重要治疗靶点。

相似文献

1
Attenuation by butalbital of capsaicin-induced c-fos-like immunoreactivity in trigeminal nucleus caudalis.布他比妥对辣椒素诱导的三叉神经脊束核中c-fos样免疫反应性的减弱作用。
Headache. 1999 Nov-Dec;39(10):697-704. doi: 10.1046/j.1526-4610.1999.3910697.x.
2
Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.丙戊酸盐对脑池内注射辣椒素诱导的三叉神经尾侧核中c-fos免疫反应性的减弱作用。
Br J Pharmacol. 1995 Dec;116(8):3199-204. doi: 10.1111/j.1476-5381.1995.tb15124.x.
3
Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.舒马曲坦类似物CP - 122,288对脑池内注射辣椒素诱导的三叉神经脊束核中c - fos免疫反应性的抑制作用
Br J Pharmacol. 1995 Mar;114(5):987-92. doi: 10.1111/j.1476-5381.1995.tb13302.x.
4
Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.5-HT(7) 受体增加辣椒素诱导的三叉神经 Fos 样免疫反应。
Headache. 2011 Nov-Dec;51(10):1511-9. doi: 10.1111/j.1526-4610.2011.02011.x.
5
The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.非肽类神经激肽-1拮抗剂RPR 100893可降低化学性硬脑膜刺激后三叉神经尾侧核中c-fos的表达。
Neuroscience. 1995 Feb;64(3):741-50. doi: 10.1016/0306-4522(94)00428-8.
6
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.CP-93,129、舒马曲坦、双氢麦角胺可阻断由化学刺激脑膜引起的大鼠三叉神经尾侧核内c-fos的表达。
Br J Pharmacol. 1992 Jun;106(2):409-15. doi: 10.1111/j.1476-5381.1992.tb14348.x.
7
5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.5-羟色胺(1B/1D)和5-羟色胺1F受体抑制辣椒素诱导的小鼠三叉神经尾侧核内的c-fos免疫反应性。
Cephalalgia. 2002 Jun;22(5):384-94. doi: 10.1046/j.1468-2982.2002.00382.x.
8
Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis.非NMDA型谷氨酸受体调节辣椒素诱导的三叉神经尾侧核内c-fos的表达。
Br J Pharmacol. 1999 Jun;127(3):623-30. doi: 10.1038/sj.bjp.0702584.
9
The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis.N-甲基-D-天冬氨酸(NMDA)受体拮抗剂MK-801可降低辣椒素诱导的大鼠三叉神经尾侧核内c-fos蛋白的表达。
Pain. 1998 May;76(1-2):239-48. doi: 10.1016/s0304-3959(98)00051-7.
10
Brainstem neurons expressing c-Fos immunoreactivity following irritant chemical stimulation of the rat's tongue.大鼠舌部受到刺激性化学物质刺激后表达c-Fos免疫反应性的脑干神经元。
Neuroscience. 1995 Dec;69(3):939-53. doi: 10.1016/0306-4522(95)00297-v.

引用本文的文献

1
Hispidulin Isolated from the Leaves of Clerodendrum inerme (L.) Gaertn Suppresses Trigeminovascular System Activation in a Rat Model Mimicking Migraine.从假茉莉叶中分离得到的滨蓟黄素可抑制偏头痛大鼠模型中的三叉神经血管系统激活。
Pharm Res. 2025 May 9. doi: 10.1007/s11095-025-03864-w.
2
The deuterated pyrazoloquinolinone targeting α6 subunit-containing GABA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy.靶向含α6亚基的GABA受体的氘代吡唑并喹啉酮作为抑制三叉神经血管系统激活的新型候选药物:对偏头痛治疗的意义。
Front Pharmacol. 2024 Aug 26;15:1451634. doi: 10.3389/fphar.2024.1451634. eCollection 2024.
3
Models of Trigeminal Activation: Is There an Animal Model of Migraine?
三叉神经激活模型:是否存在偏头痛的动物模型?
Brain Sci. 2024 Mar 27;14(4):317. doi: 10.3390/brainsci14040317.
4
Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats.丙戊酸和托吡酯对大鼠偏头痛的年龄依赖性抗偏头痛作用。
Front Pharmacol. 2018 Sep 25;9:1095. doi: 10.3389/fphar.2018.01095. eCollection 2018.
5
The α6 subunit-containing GABA receptor: A novel drug target for inhibition of trigeminal activation.含 α6 亚基的 GABA 受体:抑制三叉神经激活的新药物靶点。
Neuropharmacology. 2018 Sep 15;140:1-13. doi: 10.1016/j.neuropharm.2018.07.017. Epub 2018 Jul 21.